Pioglitazone Effect on Clinical Outcome and Inflammatory Response in patients with type 2 diabetes mellitus and COVID-19: A Randomized Clinical Trial

Pioglitazone Effect on Clinical Outcome and Inflammatory Response in patients with type 2 diabetes mellitus and COVID-19: A Randomized Clinical Trial

<h3>Background</h3><p dir="ltr">The pandemic of COVID-19 infection has emerged as a rapidly spreading communicable disease across the globe. Patients with diabetes mellitus are at a higher risk of mortality from COVID-19, mainly due to the chronic. inflammatory state asso...

Full description

Saved in:
Bibliographic Details
Main Author: Eman Elmekaty (14777932) (author)
Other Authors: Khaled Baagar (7487690) (author), Amin Jayyousi (3158868) (author), Thamer Alessa (10534630) (author), Muhammad Abdul-Ghani (4707436) (author), Mohamed Abu-Farha (25322) (author), Ali Senosi Omrani (18505373) (author), Jose Ceruto (18505376) (author), Mohammad Khair Hamad (18505379) (author), Muhammad Zaka-Ul Haq (18505380) (author), Abdul Safi, Bassem Alhariri (18505381) (author), Manish Barman (18505384) (author), Alaaeldin Abdelmajid (12535542) (author), Pioglitazone and COVID-19 study group (18505385) (author)
Published: 2024
Subjects:
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Clinical sciences
Pharmacology and pharmaceutical sciences
Coronavirus
COVID-19
Diabetes Mellitus
Pioglitazone
RCT
Qatar Health Congress 2023 and the 3rd Qatar Public Health Conference
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items